How severe is chronic hepatitis with HCV genotype 1b? a study of 1,220 cases on the waiting list for antiviral therapy in Romania

Journal of Gastrointestinal and Liver Diseases

Volumn 20, Issue 1, 2011, Pages 51-55

  Pascu, Oliviu ^a   Gheorghe, Liana ^b   Voiculescu, Mihai ^b   Ceausu, Emanoil ^c   Mateescu, Bogdan ^c,d  

^a REGIONAL INSTITUTE OF GASTROENTEROLOGY AND HEPATOLOGY   (Romania)

^b FUNDENI CLINICAL INSTITUTE   (Romania)

^c VICTOR BABES NATIONAL INSTITUTE OF PATHOLOGY   (Romania)

^d Carol Davila School of Medicine   (Romania)

Author keywords

Chronic hepatitis c; HCV genotype 1b; Histological scores; Severity; Viral load

Indexed keywords

ANTIVIRUS AGENT;

ADULT; ANTIVIRAL THERAPY; ARTICLE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; INFLAMMATION; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; ROMANIA; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; ROMANIA; VIRAL LOAD; WAITING LISTS;

EID: 79953671501     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Gheorghe L, Csiki IE, Iacob S, Gheorghe C, Smira G, Regep L. The prevalence and risk factors of hepatitis C infection in adult population in Romania: a nationwide survey 2006-2008. J Gastrointestin Liver Dis 2010; 19:373-379.
2. Voiculescu M, Iliescu L, Ionescu C, et al. A cross-sectional epidemiological study of HBV, HVC, HDV and HEV prevalence in the subCarpathian and south-eastern region of Romania. J Gastrointestin Liver Dis 2010;19:43-48.
3. Grigorescu M. HCV genotype 1 is almost exclusively present in Romaniaan patients with chronic hepatitits C. J Gastrointestin Liver Dis 2009;18:45-50.
4. Nousbaum J, Pol S, Nalpas B, et al. Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group. Ann Intern Med 1995;122: 161-168.
5. Mahaney K, Tedeschi V, Maertens G, et al. Genotypic analysis of hepatitis C virus in American patients. Hepatology 1994;20:1405-1411.
6. Lopez-Labrador FX, Ampurdanes S, Forns X, et al. Hepatitis C virus genotypes in Spanish patients with chronic HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma. J Hepatol 1997; 27: 959-965.
7. Pyenson B, Fitch K, Iwasaki K. Consequences of Hepatitis C virus (HCV) Milliman Report May, New York, 2009.
8. Freeman AJ, Dore GJ, Law MG, et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 2001;34: 809-816.
9. Benvegnu L, Gios M, Boccato S, Alberti A. Natural history of compensated viral cirrhosis: a prospective study on incidence and hierarchy of major complications. Hepatology 2004;53:744-749.
10. Gheorghe L, Baculea S. Cost-effectiveness of peginterferon alpha-2a and peginterferon alpha-2b combination regimens in genotype-1 naive patients with chronic hepatitis C. Hepatogastroenterology 2010;57:939-944.
11. Shiffmann ML. Natural history and risk factors for progression of hepatitis C virus disease and development of hepatocellular cancer before liver transplantation. Liver Transpl 2003;9:S14-S20.
12. Alberti A, Chemello L, Benvegnu L. Natural history of hepatitis C. J Hepatol 1999; 31 (Suppl 1):17-24.
13. Zeuzem S, Buti M, Ferenci P, et al. Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia. J Hepatol 2006;44:97-103.
14. Ghany MG, Strader DB, Thomas DL, Seeff LB; American Association for the Study of Liver Diseases. Diagnosis, management and treatment of hepatitis C: an update. Hepatology 2009;49:1335-1374.
15. Gheorghe L, Pascu O, Ceausu E, et al. Access to peginterferon plus ribavirin therapy for hepatitis C in Romania between 2002-2009. J Gastrointestin Liver Dis 2010;19:161-167.
16. Sangiovanni A, Prati GM, Fasani P, et al. The natural history of compensated cirrhosis due to hepatitis C virus: A 17 year cohort study of 214 patients. Hepatology 2006:43:1303-1310.
17. Ordinul MS si CNAS no. 1301/500/2008 Monitorul official al Romaniei partea I-531 si 531 bis, 2008: 231-245.
18. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24:289-293.
19. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-699.
20. Shiffman ML, Diago M, Tran A, et al. Chronic hepatitis C in patients with persistently normal alanine tranaminase levels. Clin Gastroenterol Hepatol 2006:4: 645-652.
21. Persico M, Persico E, Suozzo R, et al. Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels. Gastroenterology 2000;118:760-764.
22. Strader DB, Seeff LB. The natural history of chronic hepatitis C infection. Eur J Gastroenterol Hepatol 1996;8:324-328.
23. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002; 36(5 Suppl 1): S35-S46.
24. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patient with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997:349:825-832.
25. Yano M, Kumada H, Kage M, et al. The long-term pathological evolution of chronic hepatitis C. Hepatology 1996;23:1334-1340.
26. Wong VS, Wight DG, Palmer CR, Alexander GJ. Fibrosis and other histological features in chronic hepatitis C virus infection: a statistical model. J Clin Pathol 1996;49:465-469.
27. Ge D, Fellay J, Thompson AJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009;461:399-401.
28. Poynard T, Colombo M, Bruix J, et al. Peginterferon alfa-2b and ribavirin: effective in patiants with hepatic hepatitis C who failed interferon alfa/ribavirin therapy. Gastroenterology 2009;136:1618-1628.e2.
29. Ferenci P, Laferl H, Scherzer TM, et al. Austrian Hepatitis Study Group. Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response. Gastroenterology 2008; 135:451-458.
30. Ferreira-Gonzales A, Shiffman ML. Use of diagnostic testing for managing hepatitis C virus infection. Semin Liver Dis 2004;24 (suppl 2):9-18.
31. Garcia-Tsao G, Sanyal AJ, Grace ND, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Am J Gastroenterol 2007;102:2086-2102.
32. Garcia-Tsao G, Chung RT. Managing the complications of cirrhosis. Clinical Care Options: Hepatitis - Hepatitis Annual Update 2008: http://www.clinicaloptions.com/Hepatitis/Annual%20Updates/2008%20Annual%20Update.aspx.